Figure 6.
Histopathological examination of organs and tumor tissues in SK-BR-3 xenograft model after the treatment (hematoxylin-eosin staining, ×200). (A) Control group; (B) Taxol®; (C) Abraxane®; (D) Abra/anti-HER2
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.